Examples of using Absolute bioavailability in English and their translations into Danish
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
The absolute bioavailability is 86±18.
Following subcutaneous administration, the absolute bioavailability is about 70.
The absolute bioavailability is unknown.
Absorption After subcutaneous administration, omalizumab is absorbed with an average absolute bioavailability of 62.
The absolute bioavailability is not known.
Absorption After subcutaneous dosing, fondaparinux is completely and rapidly absorbed absolute bioavailability 100.
Absolute bioavailability of raloxifene is 2.
Following subcutaneous administration, the absolute bioavailability is approximately 60%; the terminal half-life is slightly prolonged.
Absolute bioavailability has not been determined.
Absorption Mean absolute bioavailability for imatinib is 98.
Absolute bioavailability is greater than 80.
Both clearance and absolute bioavailability decrease with increasing dose.
Absolute bioavailability averaged 4% CV 73%, range.
Absorption Mean absolute bioavailability for the capsule formulation is 98.
Absolute bioavailability is estimated to be approximately 100.
Mean absolute bioavailability is 23.
Absolute bioavailability has been calculated as between 64% and 80.
Absorption The absolute bioavailability of rivaroxaban is high(80%- 100%) for the 10 mg dose.
The absolute bioavailability of Thelin is between 70 and 100.
The absolute bioavailability has not been determined.
The absolute bioavailability amounts to approximately 91.
The absolute bioavailability of betaine has not been determined.
The absolute bioavailability of VIRACEPT has not been determined.
The absolute bioavailability of raltegravir has not been established.
The absolute bioavailability of rimonabant has not been determined.
The absolute bioavailability is about 57% after a single dose of 800 mg.
Absolute bioavailability is 40% to 45% due to presystemic metabolism.
The absolute bioavailability after transdermal application is approximately 37.
Absolute bioavailability of the febuxostat tablet formulation has not been studied.
The absolute bioavailability is reduced approximately 16% in patients with heart failure.